- Home
- SGHT vs AWP Comparison
SGHT vs AWP Comparison
Compare SGHT & AWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- AWP
- Stock Information
- Founded
- SGHT 2011
- AWP 2007
- Country
- SGHT United States
- AWP United States
- Employees
- SGHT N/A
- AWP N/A
- Industry
- SGHT Medical Specialities
- AWP Trusts Except Educational Religious and Charitable
- Sector
- SGHT Health Care
- AWP Finance
- Exchange
- SGHT Nasdaq
- AWP Nasdaq
- Market Cap
- SGHT 222.3M
- AWP 335.3M
- IPO Year
- SGHT 2021
- AWP N/A
- Fundamental
- Price
- SGHT $3.64
- AWP $3.84
- Analyst Decision
- SGHT Buy
- AWP
- Analyst Count
- SGHT 8
- AWP 0
- Target Price
- SGHT $4.01
- AWP N/A
- AVG Volume (30 Days)
- SGHT 164.1K
- AWP 331.5K
- Earning Date
- SGHT 07-31-2025
- AWP 01-01-0001
- Dividend Yield
- SGHT N/A
- AWP 12.48%
- EPS Growth
- SGHT N/A
- AWP N/A
- EPS
- SGHT N/A
- AWP N/A
- Revenue
- SGHT $78,109,000.00
- AWP N/A
- Revenue This Year
- SGHT N/A
- AWP N/A
- Revenue Next Year
- SGHT $11.60
- AWP N/A
- P/E Ratio
- SGHT N/A
- AWP N/A
- Revenue Growth
- SGHT N/A
- AWP N/A
- 52 Week Low
- SGHT $2.03
- AWP $3.06
- 52 Week High
- SGHT $8.45
- AWP $4.20
- Technical
- Relative Strength Index (RSI)
- SGHT 38.36
- AWP 34.39
- Support Level
- SGHT $3.37
- AWP $3.86
- Resistance Level
- SGHT $3.60
- AWP $3.94
- Average True Range (ATR)
- SGHT 0.23
- AWP 0.05
- MACD
- SGHT -0.12
- AWP -0.01
- Stochastic Oscillator
- SGHT 8.21
- AWP 3.03
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About AWP abrdn Global Premier Properties Fund of Beneficial Interest
Aberdeen Global Premier Properties Fund is a diversified, closed-end management investment company. Its objective is to seek high current income and capital appreciation. It predominantly invests in equity and debt securities of domestic and foreign issuers which are principally engaged in the real estate industry, real estate financing or control real estate assets. Its portfolio of investments consists securities of Industrial REITs, Retail REITs, Data Center REITs, Health Care REITs and others.